文献速递糖尿病

德国COVID-19疫情期间儿童和青少年1型糖尿病发病率:DPV登记研究结果

Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry.
PubMed 文献 · Diabetes Care · 2022-01-01

基于德国多中心糖尿病前瞻性随访登记(DPV),分析2020年1月1日至2021年6月30日儿童和青少年1型糖尿病发病率,并与2011-2019年数据推算的预期发病率比较。观察发病率显著高于预期(24.4 vs 21.2/10万人年;IRR 1.15,P<0.001),多个单月IRR显著升高。结论认为疫情期间1型糖尿病发病率显著增加,高峰较COVID-19高峰及防控措施延迟约3个月,原因未知,更可能为间接效应。

要点

  • 2020/21年观察发病率为24.4/10万人年,显著高于预期21.2/10万人年(IRR 1.15,P<0.001)。
  • 2020年6月、7月及2021年3月、6月单月IRR显著升高。
  • 发病高峰较COVID-19高峰及防控措施延迟约3个月,原因未知。

核心结论

  • COVID-19疫情期间德国儿童和青少年1型糖尿病发病率显著增加,发病高峰较COVID-19高峰及防控措施延迟约3个月,潜在原因未知,更可能为疫情的间接效应而非直接效应。

研究设计与样本

  • 基于德国多中心糖尿病前瞻性随访登记(DPV)数据,分析2020年1月1日至2021年6月30日儿童和青少年1型糖尿病发病率(每10万人年)。
  • 采用泊松回归模型,基于2011-2019年数据估算2020/21年预期发病率,并与观察发病率比较,计算发病率比(IRR)及95%CI。

主要发现

  • 2020年1月1日至2021年6月30日,德国登记新发1型糖尿病儿童和青少年5162例。
  • 2020/21年观察发病率为24.4(95%CI 23.6-25.2)/10万人年,显著高于预期21.2(95%CI 20.5-21.9)/10万人年;IRR 1.15(95%CI 1.10-1.20),P<0.001。
  • 2020年6月IRR 1.43(95%CI 1.07-1.90),P=0.003;2020年7月IRR 1.48(95%CI 1.12-1.96),P<0.001;2021年3月IRR 1.29(95%CI 1.01-1.65),P=0.028;2021年6月IRR 1.39(95%CI 1.04-1.85),P=0.010。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to investigate the incidence of type 1 diabetes in children and adolescents during the coronavirus disease 2019 (COVID-19) pandemic in Germany compared with previous years. RESEARCH DESIGN AND METHODS: Based on data from the multicenter German Diabetes Prospective Follow-up Registry, we analyzed the incidence of type 1 diabetes per 100,000 patient-years in children and adolescents from 1 January 2020 through 30 June 2021. Using Poisson regression models, expected incidences for 2020/21 were estimated based on the data from 2011 to 2019 and compared with observed incidences in 2020/21 by estimating incidence rate ratios (IRRs) with 95% CIs. RESULTS: From 1 January 2020 to 30 June 2021, 5,162 children and adolescents with new-onset type 1 diabetes in Germany were registered. The observed incidence in 2020/21 was significantly higher than the expected incidence (24.4 [95% CI 23.6-25.2] vs. 21.2 [20.5-21.9]; IRR 1.15 [1.10-1.20]; P < 0.001). IRRs were significantly elevated in June 2020 (IRR 1.43 [1.07-1.90]; P = 0.003), July 2020 (IRR 1.48 [1.12-1.96]; P < 0.001), March 2021 (IRR 1.29 [1.01-1.65]; P = 0.028), and June 2021 (IRR 1.39 [1.04-1.85]; P = 0.010). CONCLUSIONS: A significant increase in the incidence of type 1 diabetes in children was observed during the COVID-19 pandemic, with a delay in the peak incidence of type 1 diabetes by ∼3 months after the peak COVID-19 incidence and also after pandemic containment measures. The underlying causes are yet unknown. However, indirect rather than direct effects of the pandemic are more likely to be the cause.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Kamrath C, Rosenbauer J, Eckert AJ, et al. Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry. Diabetes Care. 2022. PMID: 35043145. doi:10.2337/dc21-0969

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。